184 related articles for article (PubMed ID: 10875750)
1. Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.
Kuro T; Kohnou K; Kobayashi Y; Takaoka M; Opgenorth TJ; Wessale JL; Matsumura Y
Jpn J Pharmacol; 2000 Apr; 82(4):307-16. PubMed ID: 10875750
[TBL] [Abstract][Full Text] [Related]
2. Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats.
Itoh M; Takaoka M; Shibata A; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2001 Aug; 298(2):501-7. PubMed ID: 11454911
[TBL] [Abstract][Full Text] [Related]
3. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
[TBL] [Abstract][Full Text] [Related]
4. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
Forbes JM; Hewitson TD; Becker GJ; Jones CL
Kidney Int; 2001 Apr; 59(4):1333-41. PubMed ID: 11260394
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.
Matsumura Y; Kuro T; Kobayashi Y; Umekawa K; Ohashi N; Takaoka M
Jpn J Pharmacol; 2000 Sep; 84(1):16-24. PubMed ID: 11043448
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats.
Kusumoto K; Kubo K; Kandori H; Kitayoshi T; Sato S; Wakimasu M; Watanabe T; Fujino M
Life Sci; 1994; 55(4):301-10. PubMed ID: 8028448
[TBL] [Abstract][Full Text] [Related]
8. KB-R7943, a selective Na+/Ca2+ exchange inhibitor, protects against ischemic acute renal failure in mice by inhibiting renal endothelin-1 overproduction.
Yamashita J; Ogata M; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2001 Mar; 37(3):271-9. PubMed ID: 11243417
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure.
Nishida M; Ieshima M; Konishi F; Yamashita J; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2002 Oct; 40(4):586-93. PubMed ID: 12352321
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide protects against ischemic acute renal failure through the suppression of renal endothelin-1 overproduction.
Kurata H; Takaoka M; Kubo Y; Katayama T; Tsutsui H; Takayama J; Matsumura Y
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S455-8. PubMed ID: 15838347
[TBL] [Abstract][Full Text] [Related]
11. Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction.
Fujii T; Takaoka M; Ohkita M; Matsumura Y
Biol Pharm Bull; 2005 Apr; 28(4):641-5. PubMed ID: 15802802
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of alpha-lipoic acid against ischaemic acute renal failure in rats.
Takaoka M; Ohkita M; Kobayashi Y; Yuba M; Matsumura Y
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):189-94. PubMed ID: 11906481
[TBL] [Abstract][Full Text] [Related]
13. Pre- or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure.
Yamashita J; Itoh M; Kuro T; Kobayashi Y; Ogata M; Takaoka M; Matsumura Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):412-9. PubMed ID: 11160625
[TBL] [Abstract][Full Text] [Related]
14. Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dog.
Krause SM; Walsh TF; Greenlee WJ; Ranaei R; Williams DL; Kivlighn SD
J Am Soc Nephrol; 1997 Jul; 8(7):1061-71. PubMed ID: 9219155
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide in the suppressive effect of 17beta-estradiol on endothelin-1 overproduction in ischemic acute renal failure.
Shibata Y; Takaoka M; Maekawa D; Kuwahara C; Matsumura Y
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S459-61. PubMed ID: 15838348
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.
Matsumura Y; Nishiura M; Deguchi S; Hashimoto N; Ogawa T; Seo R
J Pharmacol Exp Ther; 1998 Dec; 287(3):1084-91. PubMed ID: 9864296
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury.
Nakajima A; Ueda K; Takaoka M; Yoshimi Y; Matsumura Y
J Pharmacol Exp Ther; 2006 Mar; 316(3):1038-46. PubMed ID: 16306274
[TBL] [Abstract][Full Text] [Related]
18. Selective antagonism of the postsynaptic alpha(1)-adrenoceptor is protective against ischemic acute renal failure in rats.
Fujii T; Sugiura T; Ohkita M; Kobuchi S; Takaoka M; Matsumura Y
Eur J Pharmacol; 2007 Nov; 574(2-3):185-91. PubMed ID: 17651724
[TBL] [Abstract][Full Text] [Related]
19. Preventive effect of flavangenol on ischemia/reperfusion-induced acute renal failure in rats.
Ohkita M; Nakajima A; Ueda K; Takaoka M; Kiso Y; Matsumura Y
Biol Pharm Bull; 2005 Sep; 28(9):1655-7. PubMed ID: 16141534
[TBL] [Abstract][Full Text] [Related]
20. Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats.
Nakajima A; Ueda K; Takaoka M; Kurata H; Takayama J; Ohkita M; Matsumura Y
Biol Pharm Bull; 2006 Mar; 29(3):577-9. PubMed ID: 16508172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
